2017
DOI: 10.21276/ijlssr.2017.3.5.8
|View full text |Cite
|
Sign up to set email alerts
|

TRPC 6 as a Molecular Target in Diabetic Nephropathy

Abstract: ABSTRACT-Transient Receptor Potential Canonical (TRPC6) assumes vital part in pathophysiology of DN and is up-regulated by angiotensin II, high glucose level, Transforming growth factor beta (TGFβ), and intercede podocyte damage in Diabetes Mellitus focusing on TRPC6 may reduce podocyte damage and proteinuria. From different investigation and proof gave by analyst and author work on pathophysiological part of TRPC 6 and the medications which modify or restrain TRPC6 or its downstream molecular target propose t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…A new potential target in diabetic nephropathy has been identified. [43][44][45][46][47][48][49][50][51][52][53][54][55][56][57] The Wnt/β-catenin signaling pathway is involved in mesangial cell extracellular matrix (ECM) production (MCs). 58 Through the JNK/NF-B/NADPH oxidase/ROS pathway, high glucose promotes renal mesangial cell proliferation and fibronectin expression.…”
Section: Diabetic Nephropathymentioning
confidence: 99%
“…A new potential target in diabetic nephropathy has been identified. [43][44][45][46][47][48][49][50][51][52][53][54][55][56][57] The Wnt/β-catenin signaling pathway is involved in mesangial cell extracellular matrix (ECM) production (MCs). 58 Through the JNK/NF-B/NADPH oxidase/ROS pathway, high glucose promotes renal mesangial cell proliferation and fibronectin expression.…”
Section: Diabetic Nephropathymentioning
confidence: 99%
“…[31] The calcium phosphate nanoparticles, which are nontoxic and biodegradable can be used to deliver drug, genes activators or siRNA or combination or multidrug if the challenges are met. further investigations must done using drug targeting precise molecular pathway in DN [33] and evaluation of evidence gave by expert and author work on pathophysiological role of TRPC 6 and the medicinal drugs which regulate or restrain TRPC6 or its downstream molecular target propose that TRPC6 is unique molecular target. [34] Oxidative Stress and Heart Disease-Traditional vascular risk factors, including hyperlipidemia (cholesterol, LDL, etc.…”
Section: Glycemic Load (Gl)-mentioning
confidence: 99%